223 related articles for article (PubMed ID: 26002134)
1. Partial splenic embolization for thrombocytopenia in liver cirrhosis: predictive factors for platelet increment and risk factors for major complications.
Cai M; Huang W; Lin C; Li Z; Qian J; Huang M; Zeng Z; Huang J; Shan H; Zhu K
Eur Radiol; 2016 Feb; 26(2):370-80. PubMed ID: 26002134
[TBL] [Abstract][Full Text] [Related]
2. Predictive factors for platelet increase after partial splenic embolization in liver cirrhosis patients.
Hayashi H; Beppu T; Masuda T; Mizumoto T; Takahashi M; Ishiko T; Takamori H; Kanemitsu K; Hirota M; Baba H
J Gastroenterol Hepatol; 2007 Oct; 22(10):1638-42. PubMed ID: 17683504
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic factors considered according to the preoperative splenic volume for a prolonged increase in platelet count after partial splenic embolization for liver cirrhosis.
Hayashi H; Beppu T; Okabe K; Masuda T; Okabe H; Ishiko T; Baba H
J Gastroenterol; 2010 May; 45(5):554-9. PubMed ID: 20047119
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for complications after partial splenic embolization for liver cirrhosis.
Hayashi H; Beppu T; Okabe K; Masuda T; Okabe H; Baba H
Br J Surg; 2008 Jun; 95(6):744-50. PubMed ID: 18412294
[TBL] [Abstract][Full Text] [Related]
5. Large splenic volume may be a useful predictor for partial splenic embolization-induced liver functional improvement in cirrhotic patients.
Hayashi H; Beppu T; Masuda T; Okabe H; Imai K; Hashimoto D; Ikuta Y; Chikamoto A; Watanabe M; Baba H
J Hepatobiliary Pancreat Sci; 2014 Jan; 21(1):51-7. PubMed ID: 23798315
[TBL] [Abstract][Full Text] [Related]
6. Partial splenic embolization for hypersplenism in cirrhosis: a long-term outcome in 62 patients.
Zhu K; Meng X; Qian J; Huang M; Li Z; Guan S; Jiang Z; Shan H
Dig Liver Dis; 2009 Jun; 41(6):411-6. PubMed ID: 19070555
[TBL] [Abstract][Full Text] [Related]
7. Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients.
N'Kontchou G; Seror O; Bourcier V; Mohand D; Ajavon Y; Castera L; Grando-Lemaire V; Ganne-Carrie N; Sellier N; Trinchet JC; Beaugrand M
Eur J Gastroenterol Hepatol; 2005 Feb; 17(2):179-84. PubMed ID: 15674095
[TBL] [Abstract][Full Text] [Related]
8. Partial splenic embolization using polyvinyl alcohol particles for hypersplenism in cirrhosis: a prospective randomized study.
Zhu K; Meng X; Li Z; Huang M; Guan S; Jiang Z; Shan H
Eur J Radiol; 2008 Apr; 66(1):100-6. PubMed ID: 17532166
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the effect of partial splenic embolization on platelet values for liver cirrhosis patients with thrombocytopenia.
Lee CM; Leung TK; Wang HJ; Lee WH; Shen LK; Liu JD; Chang CC; Chen YY
World J Gastroenterol; 2007 Jan; 13(4):619-22. PubMed ID: 17278231
[TBL] [Abstract][Full Text] [Related]
10. Bevacizumab Does Not Influence the Efficacy of Partial Splenic Embolization in the Management of Chemotherapy-Induced Hypersplenism.
Jácome AA; Ohinata A; Mahvash A; Overman MJ; Kee B; Fogelman D; Morris VK; Johnson B; Rothschild ND; Wolff RA; Eng C
Clin Colorectal Cancer; 2020 Dec; 19(4):e189-e199. PubMed ID: 32680816
[TBL] [Abstract][Full Text] [Related]
11. Complications of partial splenic embolization in cirrhotic patients.
Sakai T; Shiraki K; Inoue H; Sugimoto K; Ohmori S; Murata K; Takase K; Nakano T
Dig Dis Sci; 2002 Feb; 47(2):388-91. PubMed ID: 11855556
[TBL] [Abstract][Full Text] [Related]
12. Partial splenic embolization for hypersplenism in cirrhotic patients. A case series.
Omer S; Zara O; Iacobescu C; Dina I
J Gastrointestin Liver Dis; 2014 Jun; 23(2):215-8. PubMed ID: 24949616
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Efficacy and Safety of Partial Splenic Embolization in Hepatocellular Carcinoma Patients with Thrombocytopenia Who Underwent Transarterial Chemoembolization.
Kim NH; Kim HJ; Cho YK; Hong HP; Kim BI
J Korean Med Sci; 2019 Aug; 34(30):e208. PubMed ID: 31373186
[TBL] [Abstract][Full Text] [Related]
14. Changes in platelet kinetics after a partial splenic arterial embolization in cirrhotic patients with hypersplenism.
Noguchi H; Hirai K; Aoki Y; Sakata K; Tanikawa K
Hepatology; 1995 Dec; 22(6):1682-8. PubMed ID: 7489974
[TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy of partial splenic embolization in children.
Nio M; Hayashi Y; Sano N; Ishii T; Sasaki H; Ohi R
J Pediatr Surg; 2003 Dec; 38(12):1760-2. PubMed ID: 14666461
[TBL] [Abstract][Full Text] [Related]
16. Changes in splenic volume after partial splenic embolization in children.
Watanabe Y; Todani T; Noda T
J Pediatr Surg; 1996 Feb; 31(2):241-4. PubMed ID: 8938350
[TBL] [Abstract][Full Text] [Related]
17. Role of partial splenic arterial embolization for hypersplenism in patients with liver cirrhosis and thrombocytopenia.
Abdella HM; Abd-El-Moez AT; Abu El-Maaty ME; Helmy AZ
Indian J Gastroenterol; 2010 Mar; 29(2):59-61. PubMed ID: 20443100
[TBL] [Abstract][Full Text] [Related]
18. Partial splenic embolization in the treatment of prolonged thrombocytopenia due to hypersplenism in metastatic cancer patients.
Passhak M; Shachar SS; Ofer A; Beny A
Support Care Cancer; 2018 Oct; 26(10):3527-3532. PubMed ID: 29696427
[TBL] [Abstract][Full Text] [Related]
19. The role and evolution of partial splenic embolization over three decades: A multicentric retrospective single cohort study of 90 patients from French nationwide experience.
Leideck P; Nkontchou G; Elkrief L; Erard D; d'Alteroche L; Radenne S; Billioud C; Meszaros M; Regnault D; Pageaux GP; Hilleret MN; Tripon S; Guillaud O; Ollivier-Hourmand I; Ganne-Carrié N; Dumortier J
Clin Res Hepatol Gastroenterol; 2024 Jun; 48(6):102355. PubMed ID: 38679291
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of preoperative partial splenic embolization in hepatocellular carcinoma and hypersplenic thrombocytopenia.
Yoshidome H; Kimura F; Shimizu H; Ohtsuka M; Kato A; Yoshitomi H; Furukawa K; Takeuchi D; Takayashiki T; Suda K; Takano S; Miyazaki M
Hepatogastroenterology; 2011; 58(112):2062-6. PubMed ID: 22234078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
